Latest Posts

1 30 31 32 33

Trending News

Editor's Picks

Alkem launches generic empagliflozin low-cost diabetes drug in India

Mumbai-based Alkem Laboratories announced today the launch of generic empagliflozin and its combinations in India under the brand name “Empanorm.” The medication, which treats type-2 diabetes, chronic kidney disease, and heart failure, will be priced approximately 80 per cent lower than innovator products. The shares of Alkem Laboratories Limited were trading today at ₹4,709 down...

ALL INDIA MSMES PROMOTION AND WELFARE ASSOCIATION

Quick Links

Popular Categories

Must Read

AIMPWA © 2025- All Right Reserved. Designed and Developed by  growGX.com